An erection problem may leave desire untouched
PT-141 research found sexual responses linked to activity in the brain.
Sex may interest you even when erections have become difficult. Researchers studied desire as well as erections. Animal tests came before scans in women. Neither kind of test decides which care suits your symptoms and health.
The brief answer is that brain findings don't decide your care
An erection can become difficult even though sex still interests you. PT-141 affects sexual interest inside the brain; erection pills work around blood vessels. In early animal tests, treatment produced erections while activity rose in brain cells. In women, later scans found brain activity responding differently to sexual pictures.
The PT-141 brain findings help explain the drug's action, without measuring your chance of relief. The drug also reaches cells that influence appetite and the color of skin. Stronger desire doesn't necessarily solve the physical difficulty of getting an erection. I'd ask your doctor which evidence concerns the trouble you've actually noticed.
PT-141 activates brain cells that influence desire and appetite
PT-141 acts on proteins that receive chemical messages inside the brain [1]. The main one is the melanocortin 4 receptor, which helps control sexual interest. The drug activates a related protein less strongly, and dopamine may help increase desire [1]. Dopamine is a chemical that lets brain cells pass messages to each other.
Sildenafil and tadalafil are prescription pills that help the penis receive more blood for erections. The pills loosen muscle around blood vessels; PT-141 acts on sexual interest instead [1]. Your doctor can explain which kind of difficulty each medicine addresses. An increase in wanting sex doesn't prove that erections will become easier.
Early tests in women with obesity, meaning very high body weight, found less eating and weight loss. Those women received frequent shots as part of the experiment. The appetite findings don't make PT-141 an approved weight-loss treatment. Ask how those early tests differ from care for your sexual concern.
Early tests found erections in males and mate-seeking in female rats
Early tests in rats and monkeys produced erections with PT-141 [1]. Increased brain activity supported the finding that the drug acted there. Men struggling with erections had a response soon after treatment, with larger amounts producing stronger responses. The reported finding doesn't tell you how firm or lasting those erections were.
Female rats more often sought a male after receiving PT-141 [2]. Researchers also watched the females arch their backs to allow mating. That mating response and the rats' general movement stayed much the same. The pauses female rats took between mating attempts stayed much the same; researchers called the increased mate-seeking a first finding for a drug [2].
A 2025 experiment studied female Syrian hamsters given bremelanotide [12]. Researchers examined instructions inside brain cells for making proteins that respond to the drug. Those instructions were concentrated in cells that make dopamine, a chemical carrying brain messages. Smaller and larger drug amounts didn't change the amount of these instructions inside the cells.
The experiment also checked whether hamsters favored a location where the hamsters had mated. Such a preference can show that mating felt rewarding to the animal. PT-141 didn't strengthen that preference, offering no sign of greater reward in this test. That finding differs from effects linked to addictive drugs, but can't settle addiction risk for you.
Women reported stronger desire lasting as long as a day after treatment
Among 31 women before menopause distressed about lost desire, sexual interest increased for up to 24 hours [5]. Each woman tried both kinds of shot on separate visits. One contained medicine; the other was placebo, with no drug inside. The women and staff weren't told which visit involved medicine and which involved placebo [5].
MRI makes pictures inside the body using magnets, and these scans followed brain activity. During sexual pictures, activity in two brain areas became more closely linked. When activity in one area varied, the other tended to vary along with it. That supports an effect on sexual interest in the brain, without predicting relief for your symptoms.
PT-141 acts on desire but also brings skin and liver concerns
PT-141 activates proteins receiving hormone messages
Receptors are proteins that let cells respond to particular chemical messages [1]. Five related kinds in brain and skin cells respond to this drug. The brain response helps explain sexual interest, while the skin response explains darkening. You can feel unwanted skin effects even when desire doesn't improve.
PT-141 doesn't raise testosterone; other risks still need checking
PT-141 doesn't raise testosterone, the hormone that helps support male sexual function [12]. The drug influences interest through the brain instead [1]. Your doctor can assess whether low desire or difficulty getting an erection needs attention.
The NIH LiverTox review also reports mild rises in liver enzymes in blood [10]. Enzymes are proteins that help cells work; raised levels can suggest liver trouble. Rare liver injury was reported, though most rises in blood tests were mild. Ask your doctor what those findings mean alongside your other medicines.
Your body removes the smaller pieces left when the drug breaks apart. The review describes little interference with other drugs, though little doesn't mean none. Bring your medicine list so your doctor can check for problems.